Category Archives: Parkinson’s Treatment

Seven years after Pfizer first invested in Mission Therapeutics, a biotech that researches selectively inhibiting deubiquitylating enzymes (DUBs), the pharma giant is re-upping its commitment to the company in another sign of confidence in the field of protein degradation. Pfizers VC arm is heading up a $15 million round, announced Monday morning, and increasing its overall stake in Mission. Pfizer is also entering into a licensing agreement that would give it first dibs at negotiating exclusivity after accessing certain DUB inhibitors and screening them for their potential as drugs Continue reading →

Parkinson's disease is a progressive nervous system disorder whereby certain nerve cells (neurons) in the brain gradually break down or die. Continue reading →

Neuron breakthrough raises hopes for possible Parkinsons treatment   Financial Times One-Time Treatment Generates New Neurons, Eliminates Parkinson's Disease in Mice   UC San Diego Health New treatment shown to replace neurons damaged by Parkinson's disease in mice   BBC Focus Magazine Method to combat Parkinson's disease by astrocyte-to-neuron conversion   Nature.com Single-gene treatment cures mice of Parkinson's within three months   New Atlas View Full Coverage on Google News Continue reading →

Scientists found a way to create neurons and cure Parkinson's disease in mice, for the first time. Continue reading →

Central nervous system gene therapies and advanced technologies to provide these treatments were noted as emerging opportunities in treatment for neurological conditions such as Parkinson disease, according to review findings. Continue reading →

Stay-at-home orders and safety concerns kept many people from seeking medical treatment during the past few months. Doctors voice particular concern for those with cardiac disease Continue reading →

The National Institute on Aging has awarded a $15 million grant to the Stanford Alzheimers Disease Research Center. The award is a five-year renewal of a $7.3 million grant the institute provided to the center in 2015. Continue reading →

(MENAFN - BrandEssence Market Research Company) The Parkinson's Disease Treatment Market research report delivers a comprehensive analysis on the newest market drivers. The report also offers extracts regarding statistics, market valuation and revenue estimates, which further strengthens its status in the competitive spectrum and growth trends embraced by leading manufacturers in the business. Parkinson's disease is a neuro degenerative disorder in which parts of the brain become progressively damaged over many years. Continue reading →

Erisyon, a biotechnology company specializing in the study of proteins, was awarded agrant byThe Michael J. Fox Foundation (MJFF) to find and validate potential markers ofParkinsons diseasein its early stages Continue reading →

An innovative use of focused ultrasound being pioneered at theUniversity of Virginia School of Medicineis showing promise against glioblastoma, the deadliest brain tumor, and could prove useful against other difficult-to-treat cancers. The technique hits cancer cells with a drug that sensitizes them to sound waves, then blasts them with focused ultrasound. The sound waves create tiny bubbles inside the cancer cells, causing them to die Continue reading →